Cargando…
Dulaglutide and Insulin: How Can the AWARD Studies Help Guide Clinical Practice?
The glucagon-like peptide 1 receptor agonist (GLP-1RA) dulaglutide has many characteristics to recommend it both as a second-line agent and as an alternative to or in combination with insulin. This commentary summarises recent updates to diabetes management guidelines regarding the use of GLP-1RAs s...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Healthcare
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7376989/ https://www.ncbi.nlm.nih.gov/pubmed/32564337 http://dx.doi.org/10.1007/s13300-020-00863-5 |